BDBM238861 US10052306, 300::rac-4-(2-((3aR,6aS)-5- benzylhexahydrocyclo- penta[c]pyrrol-2(1H)- yl)-1-hydroxyethyl) phenol

SMILES OC(CN1C[C@@H]2CC(Cc3ccccc3)C[C@@H]2C1)c1ccc(O)cc1

InChI Key InChIKey=HCJJHOOZJPOUQO-HGBKABEASA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 238861   

TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Cadent Therapeutics

US Patent
LigandPNGBDBM238861(US10052306, 300 | rac-4-(2-((3aR,6aS)-5- benzylhex...)
Affinity DataIC50:  13.9nMAssay Description:To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent